Bionomics
pan inhibitors potential non reduced side effect chronic pain therapies disease related genetics gain loss of function mutations in and associated with human pain syndromes where extreme pain or no pain is experienced pan inhibitors small molecules with functional selectivity for voltage gated sodium channels and potentially compounds synthesized series patented lead candidate identified observed to reverse pain in the paw model in mice back up | Bionomics
Company
Deck Type
Sector
Industry
Deck date
April 2022
Slide
36 of 38
Similar slides by Bionomics
See diffirences between slides (animation)
IPO
December 2021
gain loss of function associated with human pain syndromes where extreme functional selectivity for voltage gated sodium channels and potentially mem compounds synthesized lead candidate identified compound ree observed to reverse pain in the paw | Bionomics
Other recent decks by Bionomics
See all presentations (5 decks)
Results
March 2023
Investor Presentation
October 2022
Investor Presentation
June 2022
IPO
December 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io